Korea’s Home-Grown New Drug Approvals Hit Record High In 2021

Yuhan’s Leclaza, Hanmi’s Rolontis Among Nods

 
• By Jung Won Shin

South Korea had a milestone year in terms of domestic new drug approvals in 2021, with multiple major pharma firms gaining nods for their in-house developed products, including the country’s first COVID-19 therapeutic, from Celltrion.

drug development
Multiple Novel Drug Approvals From Major Korean Pharmas last year • Source: Alamy

More from South Korea

More from Asia